A-S Medication Solutions manufactures a generic version of medroxyprogesterone acetate injectable contraception, which is administered every three months for birth control. This contraceptive is effective.
There is a recent study that examined women who used medroxyprogesterone acetate injections, and found that users are 5.6 times more likely to develop meningioma, a brain tumor that often requires surgery.
A-S Medication Solutions is one of several companies manufacturing this generic drug. The appeal of dosing four times a year offers convenience to the public. Yet, long-term exposure may have harmed the patients.
The 2024 BMJ study revealed many concerns about medroxyprogesterone acetate injections:
A-S Medication Solutions' product info has focused on temporary side effects. It has missed a crucial safety concern that requires surgery.
Did you get A-S Medication Solutions' injectable birth control? Did you then get diagnosed with a brain tumor? Our specialized team understands the complex medical evidence linking this medication to meningioma. Atraxia Law’s experience with pharmaceutical cases helps us vet claims based on:
We recognize that facing a brain tumor diagnosis changes everything. Let us help you understand your rights while you focus on your health. We check cases and connect clients with top dangerous drug attorneys.